News Choose Year All Years 2025 (11) 2024 (20) 2023 (28) 2022 (25) 2021 (32) 2020 (25) 2019 (17) 2018 (14) Search Press Releases Found 172 Results June 15, 2022 Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June June 6, 2022 Sernova Announces Positive Updated Phase 1/2 Clinical Data on Cell Pouch System™ at American Diabetes Association 82nd Scientific Sessions 2022 June 1, 2022 SERNOVA SHARES TO COMMENCE TRADING ON TSX ON JUNE 2, 2022 May 24, 2022 Sernova Receives Conditional Approval to Up-list to the Toronto Stock Exchange May 17, 2022 Sernova and Evotec Enter into an Exclusive Global Strategic Partnership for iPSC-Based Beta Cell Replacement Therapy to Develop and Commercialize a ‘Functional Cure’ for Diabetes May 9, 2022 Sernova Announces Abstract on Phase 1/2 Trial with Cell Pouch Selected for Oral Podium Presentation at American Diabetes Association 82nd Scientific Sessions 2022 May 5, 2022 Sernova to Participate in Multiple U.S. Healthcare Investor Conferences April 29, 2022 Sernova Announces 2022 Annual General Meeting Results March 17, 2022 Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial with Sernova’s Cell Pouch System™ in Patients with Type-1 Diabetes February 24, 2022 Sernova Corp Ranks Among Top 50 Performing Companies on the 2022 TSX Venture List «...678910...»
